MMRF Announces Enrollment Completion of CoMMpass Study

The Multiple Myeloma Research Foundation (MMRF) announced that the MMRF CoMMpass StudySM, the most comprehensive long-term genomic study ever conducted in myeloma, has reached full enrollment, with 1,000 patients now participating. The global study is mapping the genomic profile of each enrolled patient with multiple myeloma in order to advance the understanding of disease progression, including patient response to therapies, and offering insights for the development of personalized treatments that target the underlying disease biology to lead to cures.

 The ASCO Post

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.